CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

NCT05289193 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Melanoma Stage III

Interventions

DIAGNOSTIC_TEST: PET Scan
DRUG: Nivolumab
DRUG: Ipilimumab
PROCEDURE: Surgical Resection of Melanoma

Sponsor

Memorial Sloan Kettering Cancer Center